Hospital
San Jose Healthcare System, L.P.
San Jose Healthcare System, L.P. was paid $15.09M by Medicaid between Jan 2018 and Dec 2024, across 187 billing codes. Its largest line is 0450, Emergency room services — 37% of everything it billed.
33Billing provider infoSAN JOSE HEALTHCARE SYSTEM, L.P.
SAN JOSE, CA 95116
SAN JOSE, CA 95116
33aNPI1285688267assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.09M
24GClaims958,416
24DCodes billed187
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#148 of 410
Median peer was paid$6.90M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 215,165 | $4.24M | |
| 2019 | 134,266 | $2.33M | |
| 2020 | 83,722 | $863K | |
| 2021 | 114,115 | $1.20M | |
| 2022 | 134,451 | $1.80M | |
| 2023 | 153,291 | $2.35M | |
| 2024incomplete | 123,406 | $2.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 37% | 197,540 | 181,879 | $5.65M |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 11% | 8,413 | 6,721 | $1.67M |
| 99199 | Unlisted special service, procedure or report | 7.0% | 13,667 | 13,165 | $1.05M |
| J3490 | Unclassified drugs | 6.6% | 18,114 | 14,123 | $1000K |
| 0270 | 5.8% | 74,041 | 42,554 | $877K | |
| 36415 | Collection of venous blood by venipuncture | 4.0% | 17,782 | 15,167 | $606K |
| 0250 | 3.8% | 24,171 | 16,085 | $574K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.1% | 18,674 | 18,351 | $316K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 14,094 | 13,202 | $214K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 30,828 | 29,285 | $210K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 33,040 | 30,735 | $202K |
| 87400 | 1.2% | 11,516 | 11,403 | $187K |
175 more codes
| 80053 | Comprehensive metabolic panel | 1.2% | 53,013 | $184K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 13,791 | $181K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 4,231 | $167K |
| 85027 | <1% | 75,867 | $131K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 6,085 | $130K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 9,052 | $104K |
| 0762 | <1% | 765 | $91K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,564 | $89K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,993 | $76K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,750 | $66K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,935 | $57K |
| 83690 | <1% | 32,170 | $52K | |
| 84484 | <1% | 22,171 | $49K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 324 | $47K |
| 81001 | <1% | 25,640 | $43K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,122 | $43K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,854 | $41K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,614 | $40K |
| 84702 | <1% | 13,490 | $38K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,376 | $37K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,544 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,844 | $35K |
| 99283 | Emergency room visit (moderate) | <1% | 944 | $30K |
| C1729 | Catheter, drainage | <1% | 5,406 | $28K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 103 | $28K |
| 80047 | <1% | 7,328 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,622 | $27K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,634 | $25K |
| 87430 | <1% | 2,455 | $23K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 363 | $22K |
| 0272 | <1% | 4,626 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,204 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13,235 | $19K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,297 | $17K |
| 76801 | <1% | 852 | $16K | |
| 87081 | <1% | 1,542 | $15K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 10,327 | $15K |
| 72100 | <1% | 723 | $14K | |
| 73610 | <1% | 1,444 | $14K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,692 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,717 | $13K |
| 73030 | <1% | 1,093 | $13K | |
| 73630 | <1% | 1,138 | $13K | |
| 73130 | <1% | 822 | $12K | |
| 81003 | <1% | 3,093 | $12K | |
| 73562 | <1% | 860 | $12K | |
| 80076 | <1% | 6,573 | $12K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 292 | $12K |
| 99284 | Emergency room visit (serious) | <1% | 313 | $11K |
| 83880 | <1% | 3,277 | $11K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 111 | $11K |
| 87634 | <1% | 811 | $11K | |
| 76830 | Ultrasound, transvaginal | <1% | 680 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,642 | $10K |
| 73140 | <1% | 394 | $10K | |
| 94644 | <1% | 485 | $10K | |
| 93971 | <1% | 272 | $9K | |
| 74018 | <1% | 813 | $9K | |
| 70486 | <1% | 239 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 150 | $8K |
| 87077 | <1% | 1,739 | $8K | |
| 87486 | <1% | 327 | $8K | |
| 83605 | <1% | 4,695 | $8K | |
| 85730 | <1% | 7,905 | $7K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 307 | $7K |
| 82550 | <1% | 6,563 | $7K | |
| 81025 | <1% | 3,081 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 114 | $7K |
| 87040 | <1% | 3,805 | $7K | |
| 73560 | <1% | 357 | $6K | |
| 85610 | <1% | 9,044 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,459 | $6K |
| 73110 | <1% | 373 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,367 | $5K |
| 73502 | <1% | 242 | $5K | |
| 73590 | <1% | 507 | $5K | |
| 0258 | <1% | 505 | $5K | |
| 87581 | <1% | 327 | $4K | |
| 90715 | <1% | 1,556 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,591 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,741 | $4K |
| 72170 | <1% | 564 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 327 | $3K |
| 83735 | <1% | 3,796 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,371 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,566 | $3K |
| 73090 | <1% | 221 | $3K | |
| 87186 | <1% | 1,665 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 220 | $2K |
| 73620 | <1% | 154 | $2K | |
| 82077 | <1% | 1,480 | $2K | |
| 93017 | <1% | 80 | $2K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 6,083 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 41 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $2K |
| 0360 | <1% | 26 | $2K | |
| 73080 | <1% | 108 | $2K | |
| 0710 | <1% | 199 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,360 | $2K |
| V2632 | Posterior chamber intraocular lens | <1% | 13 | $2K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 36 | $2K |
| 85379 | <1% | 957 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 715 | $1K |
| 73600 | <1% | 62 | $1K | |
| 82330 | <1% | 385 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 76 | $1K |
| 73070 | <1% | 41 | $1K | |
| 86901 | <1% | 2,445 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 708 | $1K |
| 96376 | <1% | 1,242 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 110 | $1K |
| 86900 | <1% | 2,445 | $1K | |
| 87210 | <1% | 374 | $1K | |
| 73552 | <1% | 74 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 31 | $978.24 |
| 0720 | <1% | 20 | $956.54 | |
| 93970 | <1% | 12 | $918.21 | |
| 70360 | <1% | 43 | $887.80 | |
| 82553 | <1% | 382 | $831.74 | |
| 86850 | <1% | 1,512 | $818.07 | |
| 73120 | <1% | 41 | $715.04 | |
| 12001 | <1% | 152 | $668.88 | |
| 70498 | <1% | 15 | $654.24 | |
| 87147 | <1% | 257 | $637.03 | |
| 86140 | <1% | 748 | $630.11 | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 13 | $613.35 |
| 0510 | <1% | 250 | $607.02 | |
| 76870 | <1% | 54 | $551.74 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 382 | $544.68 |
| 73100 | <1% | 40 | $516.68 | |
| 70496 | <1% | 15 | $488.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 432 | $458.07 |
| 82248 | <1% | 380 | $448.49 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 210 | $414.58 |
| 80061 | Lipid panel | <1% | 151 | $403.99 |
| 84439 | <1% | 178 | $403.29 | |
| 76770 | <1% | 12 | $370.50 | |
| 99285 | Emergency room visit (most serious) | <1% | 79 | $361.69 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 316 | $331.46 |
| 87420 | <1% | 144 | $308.60 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 110 | $293.74 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 490 | $271.03 |
| 85007 | <1% | 329 | $243.41 | |
| J1815 | Injection, insulin, per 5 units | <1% | 301 | $227.97 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 810 | $225.53 |
| 87088 | <1% | 83 | $219.19 | |
| 85651 | <1% | 336 | $179.65 | |
| 72040 | <1% | 12 | $169.17 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 108 | $162.10 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 25 | $121.97 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,647 | $116.79 |
| 90714 | <1% | 70 | $96.87 | |
| 82140 | <1% | 31 | $91.02 | |
| 84100 | <1% | 58 | $66.92 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 13 | $59.69 |
| 11043 | <1% | 26 | $55.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 69 | $45.64 |
| 73660 | <1% | 13 | $44.94 | |
| 82310 | <1% | 26 | $42.30 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 153 | $38.50 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 75 | $35.76 |
| A9270 | Non-covered item or service | <1% | 2,766 | $29.75 |
| 0259 | <1% | 33 | $18.30 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 47 | $14.63 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 289 | $8.71 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 15 | $2.50 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 16 | $0.94 |
| S0028 | Injection, famotidine, 20 mg | 0% | 44 | $0.00 |
| 12011 | 0% | 53 | $0.00 | |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 48 | $0.00 |
| 82009 | 0% | 13 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 117 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 43 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 15 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialASHWORTH, FREDERICK (CFO)
| Provider | Location | Paid |
|---|---|---|
| San Jose Healthcare System, L.P. | San Jose, CA | $776K |
| San Jose Healthcare System, L.P. | San Jose, CA | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.